<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Mashhad Razavi Hospital</PublisherName>
				<JournalTitle>Razavi Journal of Medicine</JournalTitle>
				<Issn>3115-753X</Issn>
				<Volume>4</Volume>
				<Issue>2</Issue>
				<PubDate PubStatus="epublish">
					<Year>2016</Year>
					<Month>04</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>SerumPro-Oxidant-Antioxidant Balance, Advanced Oxidized Protein Products (AOPP) and Protein Carbonyl in PatientsWith Stroke</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>22</FirstPage>
			<LastPage>28</LastPage>
			<ELocationID EIdType="pii">113504</ELocationID>
			
<ELocationID EIdType="doi">10.30483/rijm.2016.116395</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Vajiheh</FirstName>
					<LastName>Toloue Pouya</LastName>
<Affiliation>Department of Biochemistry, Faculty of Medicine,Mashhad University of Medical Sciences,Mashhad, IR Iran</Affiliation>

</Author>
<Author>
					<FirstName>Seyed</FirstName>
					<LastName>Issac Hashemy</LastName>
<Affiliation>Surgical Oncology Research Center, ImamReza Hospital, Faculty of Medicine,Mashhad University of Medical Sciences,Mashhad, IR Iran</Affiliation>

</Author>
<Author>
					<FirstName>Ali</FirstName>
					<LastName>Shoeibi</LastName>
<Affiliation>Department of Neurology, GhaemHospital,Mashhad University of Medical Sciences,Mashhad, IR Iran</Affiliation>

</Author>
<Author>
					<FirstName>Abolfazl</FirstName>
					<LastName>Nosrati Tirkani</LastName>
<Affiliation>Department of Biochemistry, Faculty of Medicine,Mashhad University of Medical Sciences,Mashhad, IR Iran</Affiliation>

</Author>
<Author>
					<FirstName>Shima</FirstName>
					<LastName>Tavallaie</LastName>
<Affiliation>Biochemistry of Nutrition Research Center,Mashhad University of Medical Sciences,Mashhad, IR Iran</Affiliation>

</Author>
<Author>
					<FirstName>Farnaz</FirstName>
					<LastName>Zahedi Avval</LastName>
<Affiliation>Department of Biochemistry, Biochemistry and Nutrition Research Center, Faculty of Medicine,Mashhad University of Medical Sciences,Mashhad, IR Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mohammad</FirstName>
					<LastName>Soukhtanloo</LastName>
<Affiliation>Department of Biochemistry, Biochemistry and Nutrition Research Center, Faculty of Medicine,Mashhad University of Medical Sciences,Mashhad, IR Iran</Affiliation>

</Author>
<Author>
					<FirstName>Barat</FirstName>
					<LastName>Ali Mashkani</LastName>
<Affiliation>Department of Biochemistry, Biochemistry and Nutrition Research Center, Faculty of Medicine,Mashhad University of Medical Sciences,Mashhad, IR Iran</Affiliation>

</Author>
<Author>
					<FirstName>Daryoush</FirstName>
					<LastName>Hamidi Alamdari</LastName>
<Affiliation>Department of Biochemistry, Biochemistry and Nutrition Research Center, Faculty of Medicine,Mashhad University of Medical Sciences,Mashhad, IR Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
		<Abstract>&lt;strong&gt; Background:&lt;/strong&gt; Stroke is the second cause of death and disability in the world, and oxidative stress which could be considered as a prognostic factor in patients for prevention, follow up and determination of stroke’s severity has a conceivable role in neural damage.&lt;br /&gt; &lt;br /&gt;&lt;strong&gt; Objectives:&lt;/strong&gt; The aim of our study was to explain the association between oxidant/antioxidant imbalance as a prognostic factor in patients with stroke.&lt;br /&gt; &lt;br /&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Pro-oxidant-antioxidant balance (PAB), advanced oxidized protein products (AOPP) and protein carbonyl were measured in patients with ischemic stroke and hemorrhagic stroke as well as healthy group. Sera were collected from 18 is- chemic and 23 hemorrhagic stroke patients, and 34 healthy volunteers. The PAB assay, routine biochemical parameters, lipid proﬁle and total protein concentration were assessed in patients and healthy group.&lt;br /&gt; &lt;br /&gt;&lt;strong&gt;Results:&lt;/strong&gt; The level of AOPP (P &lt; 0.007), protein carbonyl (P &lt; 0.001) and PAB (P &lt; 0.01) were signiﬁcantly higher in stroke patients than the healthy group.&lt;br /&gt; &lt;br /&gt;&lt;strong&gt;Conclusions:&lt;/strong&gt; There are increased level of protein carbonyl, AOPP and PAB in patients with stroke. Measuring these factors may be beneﬁcial as prognostic factors in treatment and follow up of the patients with both hemorrhagic and ischemic strokes. More investigations withmore cases and longer follow up are needed to approve that these factors play an important role in prognosis of stroke.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Hemorrhagic Strokes</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Ischemic Strokes</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">oxidative stress</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">protein carbonyl</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Prognostic factor</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">PAB Assay</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">biochemical parameters</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Lipid Proﬁle</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Total Protein Concentration</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.razavihospital.ir/article_113504_1ff70043c78f44fc8841bd8203c00ed3.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
